Abivax S.A.
(Note: This is NOT an IPO. This is a NASDAQ uplisting from Euronext Paris. This is a public offering of American Depositary Shares in the U.S. and a private placement of ordinary shares in France and elsewhere in Europe.) We are a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory […]
October 16, 2023 Read More